Publication:
Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.

dc.contributor.authorKlimek, Ludger
dc.contributor.authorBergmann, Karl-Christian
dc.contributor.authorBrehler, Randolf
dc.contributor.authorPfützner, Wolfgang
dc.contributor.authorZuberbier, Torsten
dc.contributor.authorHartmann, Karin
dc.contributor.authorJakob, Thilo
dc.contributor.authorNovak, Natalija
dc.contributor.authorRing, Johannes
dc.contributor.authorMerk, Hans
dc.contributor.authorHamelmann, Eckard
dc.contributor.authorAnkermann, Tobias
dc.contributor.authorSchmidt, Sebastian
dc.contributor.authorUntersmayr, Eva
dc.contributor.authorHötzenecker, Wolfram
dc.contributor.authorJensen-Jarolim, Erika
dc.contributor.authorBrockow, Knut
dc.contributor.authorMahler, Vera
dc.contributor.authorWorm, Margitta
dc.date.accessioned2023-02-09T11:37:49Z
dc.date.available2023-02-09T11:37:49Z
dc.date.issued2021-04-19
dc.description.abstractFor the preventive treatment of the 2019 coronavirus disease (COVID-19) an unprecedented global research effort studied the safety and efficacy of new vaccine platforms that have not been previously used in humans. Less than one year after the discovery of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral sequence, these vaccines were approved for use in the European Union (EU) as well as in numerous other countries and mass vaccination efforts began. The so far in the EU approved mRNA vaccines BNT162b2 and mRNA-1273 are based on similar lipid-based nanoparticle carrier technologies; however, the lipid components differ. Severe allergic reactions and anaphylaxis after COVID-19 vaccination are very rare adverse events but have drawn attention due to potentially lethal outcomes and have triggered a high degree of uncertainty. Current knowledge on anaphylactic reactions to vaccines and specifically the new mRNA COVID-19 vaccines was compiled using a literature search in Medline, PubMed, as well as the national and international study and guideline registries, the Cochrane Library, and the Internet, with special reference to official websites of the World Health Organization (WHO), US Centers for Disease Control and Prevention (CDC), Robert Koch Institute (RKI), and Paul Ehrlich Institute (PEI). Based on the international literature and previous experience, recommendations for prophylaxis, diagnosis and therapy of these allergic reactions are given by a panel of experts. Allergy testing is not necessary for the vast majority of allergic patients prior to COVID-19 vaccination with currently licensed vaccines. In case of allergic/anaphylactic reactions after vaccination, allergy workup is recommended, as it is for a small potential risk population prior to the first vaccination. Evaluation and approval of diagnostic tests should be done for this purpose.
dc.identifier.doi10.1007/s40629-021-00165-7
dc.identifier.issn2197-0378
dc.identifier.pmcPMC8054127
dc.identifier.pmid33898162
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054127/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s40629-021-00165-7.pdf
dc.identifier.urihttp://hdl.handle.net/10668/17634
dc.issue.number3
dc.journal.titleAllergo journal international
dc.journal.titleabbreviationAllergo J Int
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number79-95
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAllergic reaction
dc.subjectAnaphylactic reaction
dc.subjectCorona virus
dc.subjectSafety
dc.subjectVaccination
dc.titlePractical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number30
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8054127.pdf
Size:
712.37 KB
Format:
Adobe Portable Document Format